C. I. Edvard SMITH

Professor

Karolinska Institutet

Sweden

Research Interests

Explore related searches

Professors in Sweden Professors in Immunology Immunology professors in Sweden

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Professor C. I. Edvard Smith is a faculty member at Karolinska Institutet, Sweden. His research focuses on immunology, diabetes, cancer biology, and the effects of COVID-19 on immunocompromised patients. Recent publications include studies on umbilical cord-derived mesenchymal stromal cells in type 1 diabetes and the immunogenicity of mRNA vaccines in various patient populations.

Articles (15)

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2022

Year:

2022

Year:

2022

Year:

2022

Year:

2021

Year:

2021

Year:

2021

Karolinska Institutet

SWEDEN

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

C. I. Edvard SMITH

Research Interests

Explore related searches

Contact this professor

About

Articles (15)

Correction: Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial

In BTK, phosphorylated Y223 in the SH3 domain mirrors catalytic activity, but does not influence biological function

Reduced clone size upon BTK inhibitor resistance mutations relates to toxicity caused by inherited PLCG2 gain‐of‐function variations

Estimating the Number of Polygenic Diseases Among Six Mutually Exclusive Entities of Non-Tumors and Cancer

Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a Phase I/II randomised double-blind placebo-controlled trial

Real-world assessment of immunogenicity in immunocompromised individuals following SARS-CoV-2 mRNA vaccination: a one-year follow-up of the prospective clinical trial COVAXID

Exposure to Therapeutic BTK Inhibitors Induces Phenocopying of Btk29A Mutants in the Fruit Fly Drosophila melanogaster

Do reduced numbers of plasmacytoid dendritic cells contribute to the aggressive clinical course of COVID‐19 in chronic lymphocytic leukaemia?

Clinical measurement of cellular DNA damage hypersensitivity in patients with DNA repair defects.

NK cell frequencies, function and correlates to vaccine outcome in BNT162b2 mRNA anti-SARS-CoV-2 vaccinated healthy and immunocompromised individuals.

Salivary IgG to SARS-CoV-2 indicates seroconversion and correlates to serum neutralization in mRNA-vaccinated immunocompromised individuals.

Safety and efficacy of the mRNA BNT162b2 vaccine against SARS-CoV-2 in five groups of immunocompromised patients and healthy controls in a prospective open-label clinical trial.

Editorial: New Insights on Bruton's Tyrosine Kinase Inhibitors.

Growth Media Conditions Influence the Secretion Route and Release Levels of Engineered Extracellular Vesicles.

Covid-19 in patients with chronic lymphocytic leukemia: clinical outcome and B- and T-cell immunity during 13 months in consecutive patients.

Collaborators (10)

Rula Zain

Michał Sobkowiak

ELISA PIN

Giulia Corso

Nicolai Sebastian Frengen

Peter Bergman

Lindsay Davies

Yu GAO

Oskar Gustafsson

Margaret Sällberg Chen

Make your next move.